Cargando…

Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic

Detalles Bibliográficos
Autor principal:	DeBaun, Michael R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	Letter to BLOOD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256359/ https://www.ncbi.nlm.nih.gov/pubmed/32282033 http://dx.doi.org/10.1182/blood.2020005992

Ejemplares similares

Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic
por: Nickel, Robert Sheppard, et al.
Publicado: (2020)

Further evidence supporting the global use of hydroxyurea
por: Archer, Natasha M.
Publicado: (2023)

Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial
por: Abdullahi, Shehu U., et al.
Publicado: (2023)

Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose
por: Terpos, Evangelos, et al.
Publicado: (2021)

Hydroxyurea: A useful adjunct to the standard antiviral therapy in chronic hepatitis B
por: Alavi-Moghaddam, Mostafa
Publicado: (2011)

Most adults with severe HbSC disease are not treated with hydroxyurea
por: Ghunney, William Kwesi, et al.
Publicado: (2023)

House calls for stem cell transplant patients during the COVID-19 pandemic
por: Sung, Anthony D., et al.
Publicado: (2020)

Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
por: Maillard, Alexis, et al.
Publicado: (2022)

Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose
por: Carsetti, Rita, et al.
Publicado: (2022)

Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies
por: Davis, James A., et al.
Publicado: (2023)

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report
por: Cuneo, Antonio, et al.
Publicado: (2020)

Cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia after a second ChAdOx1 nCoV-19 dose
por: Krzywicka, Katarzyna, et al.
Publicado: (2022)

High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients
por: Oliva-Ariza, Guillermo, et al.
Publicado: (2023)

More evidence for low-dose IL-2 for chronic GVHD in children
por: Levine, John E.
Publicado: (2023)

Intensive hydroxyurea dosing in very young children with sickle cell anemia
por: Wang, Winfred C., et al.
Publicado: (2023)

Impact of Paxlovid on international normalized ratio among patients on chronic warfarin therapy
por: Muse, Oluwatoyosi, et al.
Publicado: (2022)

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?
por: Frigault, Matthew J., et al.
Publicado: (2020)

Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies
por: Ghione, Paola, et al.
Publicado: (2021)

Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy
por: Dhakal, Binod, et al.
Publicado: (2021)

Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL
por: Rejeski, Kai, et al.
Publicado: (2022)

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
por: Henriquez, Soledad, et al.
Publicado: (2022)

Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy
por: Terpos, Evangelos, et al.
Publicado: (2022)

Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell–depleted lymphoma after CART therapy
por: Atanackovic, Djordje, et al.
Publicado: (2022)

Hydroxyurea alters hematological, biochemical and inflammatory biomarkers in Brazilian children with SCA: Investigating associations with βS haplotype and α-thalassemia
por: Yahouédéhou, Sètondji Cocou Modeste Alexandre, et al.
Publicado: (2019)

Efficacy and safety of oral hydroxyurea in transfusion-dependent β-thalassaemia: a protocol for randomised double-blind controlled clinical trial
por: Yasara, Nirmani, et al.
Publicado: (2020)

No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation
por: Cappy, Pierre, et al.
Publicado: (2020)

Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study
por: Tremblay, Douglas, et al.
Publicado: (2020)

Use of convalescent plasma in hospitalized patients with COVID-19: case series
por: Hegerova, Livia, et al.
Publicado: (2020)

Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion
por: Xia, Xinyi, et al.
Publicado: (2020)

Red cell–bound antibodies and transfusion requirements in hospitalized patients with COVID-19
por: Berzuini, Alessandra, et al.
Publicado: (2020)

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
por: Treon, Steven P., et al.
Publicado: (2020)

Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset
por: Perreault, Josée, et al.
Publicado: (2020)

The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia
por: Uzun, Günalp, et al.
Publicado: (2021)

CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
por: Plaks, Vicki, et al.
Publicado: (2021)

Vacuolization of hematopoietic precursors: an enigma with multiple etiologies
por: Gurnari, Carmelo, et al.
Publicado: (2021)

Novel somatic mutations in UBA1 as a cause of VEXAS syndrome
por: Poulter, James A., et al.
Publicado: (2021)

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
por: Pagano, Livio, et al.
Publicado: (2022)

COVID-19 as a potential trigger of complement-mediated atypical HUS
por: El Sissy, Carine, et al.
Publicado: (2021)

Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing
por: Ehrend, Elisabeth, et al.
Publicado: (2021)

Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients
por: Liebers, Nora, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a1k6615magf26vur9o41u03dfd